No Data
An Insider At Giant Biogene Holding Lowered Their Holding Recently
Zhaoying International: In February, the domestic cosmetics sales were strong, suggesting attention to brands like Mao Ge Ping.
Zhiyin International released a Research Report stating that as of March 11, the beauty stocks under focus have risen approximately 47%. It believes that in the current economic environment, cost-effectiveness is the main line of Consumer. The R&D capabilities of domestic beauty brands have gained international recognition and competitiveness has increased. The bank suggests paying attention to high growth potential symbols such as Mao Geping (01318), Juzhi Biotechnology (02367), Guangdong Marubi Biotechnology (603983.SH); symbols with high performance realization such as Proya Cosmetics (603605.SH), CHICMAX (02145); and symbols where Operation may significantly improve such as Shanghai Jahwa United (600315.SH), Betaini (3009).
[Brokerage Focus] CMB International pointed out that the February sales data for beauty products shows that domestic brands are focusing on efforts on the Douyin platform, with strong growth in the skincare category.
Jinwu Financial News | Zheshang International stated that the beauty sales data for February shows that domestic brands are making significant efforts on the Douyin platform, particularly in the skincare category, which is experiencing strong growth. Looking at the cumulative data for the first two months, Giant Bio (02367) and Mao Geping (01318) have outstanding growth rates, while Marubi (603983) and Shanghai Jahwa United (600315) show significant improvement, with clear increases compared to their quarterly growth in 2024. During the 38 major promotions, Mao Geping performed exceptionally well, successfully capturing the top spot in Douyin's makeup rankings. Proya Cosmetics and Han Shu remain firmly at the top of the overall beauty list on Tmall and Douyin. The cumulative GMV for 2M25 has increased by 10% year-on-year (compared to 2025.
Giant Biotech (02367.HK) will hold a Board of Directors meeting on March 26 to approve the annual performance.
Gelonghui, March 12丨Giant Biotech (02367.HK) announced that the Board of Directors meeting will be held on March 26, 2025, to consider and approve the company's annual performance for the year ending December 31, 2024, and to consider the proposal regarding the distribution of the final dividend (if any).
GIANT BIOGENE: DATE OF BOARD MEETING
Hong Kong stock Concept tracking | Douyin and Taotian beauty products' GMV growth is remarkable. The National Medical Products Administration supports domestic beauty brands going abroad (with accompanying Concept stocks).
The National Medical Products Administration: Strongly encourage innovation in Cosmetic ingredients and support domestic beauty brands going overseas.
